Mesenchymal stem cell-based therapy in kidney transplantation

Kidney transplantation is the best treatment for end-stage renal disease, but its implementation is limited by organ shortage and immune rejection. Side effects of current immunosuppressive drugs, such as nephrotoxicity, opportunistic infection, and tumorigenic potential, influence long-term graft o...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Cheng, Hou, Jianquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745166/
https://www.ncbi.nlm.nih.gov/pubmed/26852923
http://dx.doi.org/10.1186/s13287-016-0283-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745166/
https://www.ncbi.nlm.nih.gov/pubmed/26852923
http://dx.doi.org/10.1186/s13287-016-0283-6

Ejemplares similares